What Nolla announced
The post is two sentences and a video. Nolla Health, it says, became the first organisation in the United States, and possibly the world, to receive regulatory approval for an AI to issue initial prescriptions, which makes Nolla the first end-to-end AI doctor.
That is a claim with a regulator behind it, which is rare on X. Most AI healthcare posts describe a model or a study.
This one describes a permission: a state has allowed software to write a first prescription, with a licensed physician reviewing the care. Bloomberg covered the approval the same morning, and the thread links the article.
The product behind it is Nolla Derm, piloting in Utah for residents over 18, from $4.99 a month, starting with acne.
What Nolla Derm is, and who it is for
Nolla Health is a New York company building what it calls personal doctors: AI assessments, licensed clinicians and personalised treatment from a phone. Its founder, Luis Wenus, previously worked at Worldcoin.
Nolla Derm is the dermatology product. A patient answers questions and takes a face scan, the AI writes an acne prescription in minutes, the plan is reviewed every 28 scans, medication ships to the door or a pharmacy, and a licensed physician can be messaged at any time.
The company says the AI is built on peer-reviewed research and benchmarked against board-certified clinicians, with medical advisors from Harvard, MIT and Johns Hopkins.
The thread explains why Utah and why acne. About 100,000 Utahns have active acne and most have never seen a dermatologist, in a state with the highest melanoma incidence in the country and dermatologists stretched thin by routine cases.
Acne is common, well understood and low risk, which is the right first condition for a new kind of care. Women's health and other specialties come next.
Why a healthcare launch is the hard version
Healthcare is the category where X is least useful by default. The buyer is a patient or a clinician, the claim is regulated, and anything that sounds like a medical promise draws scrutiny before it draws interest.
The directory shows it. 46 healthtech launches sit in it, with a median of 256,018 views against 688,938 for every launch we track. Healthtech reaches well under half of what the field does.
A first-ever claim changes the shape of the problem. "An AI can now prescribe" is a sentence people have an opinion about before they finish reading it.
Physicians argue with it, founders celebrate it, patients ask whether it applies to them. That argument is what carries a post past the people who already follow the account, and it is what the launch was built to start.
What we ran
One window, around a claim with a regulator behind it. The founder account anchored the story because people follow people, and the company account amplified.
The casting followed the audience a regulated launch has to reach: founders and operators in healthcare and AI who would read the approval as a milestone, engineers and builders who would read it as a product, physicians and healthcare voices who would argue with it in public, and the tech generalists whose readers decide what the week was about.
About 80 accounts were matched to the brief, each briefed on the angle and timed in how they engaged, quote posts with a take first and more as the thread's later posts landed.
Production on the client side was a nine-post thread and a 2:05 video.
The post
Today, Nolla Health became the first organization in the U.S. (and possibly the world) to receive regulatory approval for an AI to issue initial prescriptions.
This makes Nolla the first ever actual end-to-end AI doctor.
The thread, post by post
The announcement is the first of nine posts. Each one answers the question the previous one raises, which is what lets each be quoted on its own.
- The approval. First in the US to have an AI issue initial prescriptions. The video shows the product.
- What that means. An end-to-end AI doctor: assessment, prescription and follow-up in one loop, with physicians overseeing it.
- The press. The Bloomberg piece, which is the third-party proof a regulated claim needs.
- The product. Nolla Derm: scan, prescribe, review every 28 scans, medication shipped.
- The guardrails. Licensed physicians, a defined pilot, a single state.
- Why Utah. 100,000 people with active acne, most of whom have never seen a dermatologist, in the state with the highest melanoma rate.
- Why acne first. Common, well understood, low risk. Built with dermatologists and researchers from Harvard, MIT and Johns Hopkins.
- What comes next. Women's health and other specialties, with the same complete-the-loop principle.
- The backers. Thanks to General Catalyst and the angels who supported the company.
The replies did what the structure invites. Physicians asked who is liable.
Founders called it the first real AI doctor. Patients outside Utah asked when it reaches them.
The founder answered in the thread for hours, and the quote posts ran at roughly one for every three likes in the first ninety minutes, against a directory median of one for every twenty.
The numbers, against every healthtech launch
We measure every AI launch on X we can find, so there is a healthtech median to read this against as well as the field.
| Measure | Nolla Health | Healthtech median | Directory median |
|---|---|---|---|
| Views | 2,483,444 | 256,018 | 688,938 |
| Founder followers when posted | about 2,300 | — | about 7,800 |
| Reach against that following | 1,080 times | — | 33 times |
| Quote posts | 710 | — | 39 |
| Rank by views | 364 of 1978 | — | — |
The biggest healthtech launches in the directory, for scale:
| Launch | Date | Views |
|---|---|---|
| Edison Scientific | 2026-05-19 | 7M |
| OpenEvidence | 2026-05-21 | 6.8M |
| Olio Labs | 2026-08-05 | 3.1M |
| Nolla Health | 2026-10-05 | 2.5M |
| OpenAI | 2026-04-16 | 2.4M |
| BioStack | 2026-05-25 | 2.3M |
| Google DeepMind | 2026-09-08 | 2.1M |
| NewLimit | 2026-06-02 | 2.1M |
| Ritwik Pavan | 2026-04-29 | 1.7M |
| Reservoir | 2026-10-15 | 1.5M |
| Lassie | 2026-06-03 | 1.2M |
| Superpower | 2026-04-16 | 1M |
The healthtech vertical keeps the full list current.
More views than OpenAI's own healthcare launch, from 2,300 followers
On 1 September 2026 OpenAI announced ChatGPT's integration with Epic, the electronic health record most US hospitals run on, from an account with about 5.4 million followers. The post stands at 994K views.
Nolla's announcement, from a founder account of about 2,300 followers, stands at 2.5M. A regulated healthcare claim from a company most people had never heard of out-reached the largest AI company in the world announcing a healthcare product, from an account roughly one two-thousandth of the size.
The audience for healthcare on X exists. The question is who carries the post to it.
What to watch
This page went up on launch day, and a launch day read is wrong by the next morning unless it updates, so every figure here follows the directory. Views land first. Quote posts and replies landed in the first hour, which is the casting showing.
Bookmarks on a product most readers cannot use yet are the number to read at day fourteen, because a save from someone outside Utah is a patient waiting for their state.
The figure that matters most to Nolla is the follower count on both accounts, because the next state, and the next specialty, launch to that audience.
Questions we get asked
What is Nolla Health?
Nolla Health is a New York healthcare company building AI-powered care with licensed clinicians: instant assessments, personalised treatment and a physician you can message, from a phone. Its dermatology product, Nolla Derm, is the first AI approved to issue an initial prescription in the United States, piloting in Utah from October 2026.
Can an AI legally prescribe medication in the United States?
In Utah, as of October 2026, Nolla Health says it is the first organisation to receive regulatory approval for an AI to issue an initial prescription, within a pilot for adults, with licensed physicians overseeing the care. Nolla Derm starts with acne. Other states and conditions are not covered by the approval.
How much does Nolla Derm cost?
From $4.99 a month, according to Nolla's site. The AI prescribing pilot is open to Utah residents aged 18 and over. People outside Utah can use the app without the AI prescription.
How did the Nolla Health launch do on X?
The founder's announcement stands at 2.5M views from an account that had about 2,300 followers when it posted, with 710 quote posts and 2,402 bookmarks. The figures update every half hour while the launch is moving, then daily.
Who backs Nolla Health?
General Catalyst, named in the launch thread, with a group of angel investors the founder thanked alongside it.
How did the Nolla Health launch compare with OpenAI's healthcare launch?
Nolla's founder post stands at 2.5M views from an account of about 2,300 followers. OpenAI's September announcement of its Epic EHR integration stands at 994K from about 5.4 million followers. The smaller account out-reached the larger one by about 75%, from roughly one two-thousandth of the following.
Did Doomers run the Nolla Health launch?
Doomers ran the distribution: about 80 founders, engineers and healthcare voices matched to the brief and timed in how they engaged. Nolla produced the thread and the video, and the founder answered the replies.